Skip to main content

Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron

Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.